The BIG question: Can we stop the use of HBIG?

Autor: Lee R; Department of Medicine, Riverside Community Hospital, Riverside, California, USA., Alukal JJ; Department of Medicine, Riverside Community Hospital, Riverside, California, USA.; Department of Medicine, University of California, Riverside School of Medicine, Riverside, California, USA., Gish RG; Hepatitis B Foundation, Doylestown, Pennsylvania, USA.; School of Medicine, Reno, Reno, Nevada, USA.; Department of Medicine, Las Vegas, Las Vegas, Nevada, USA.; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California, USA.; Loma Linda University Transplant Institute, Loma Linda, California, USA.
Jazyk: angličtina
Zdroj: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society [Liver Transpl] 2024 Jun 01; Vol. 30 (6), pp. 570-572. Date of Electronic Publication: 2024 Jan 31.
DOI: 10.1097/LVT.0000000000000340
Databáze: MEDLINE